Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence (Q51611058)
scientific article published in January 2005
Language:
Current Data About Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence
(P31) (Q13442814)
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P50) (Q62238911)
(P1545) 2
(P1932) P Rod Dunbar
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(Q62032604)
(P1545) 5
(P1932) Dawn Shepherd
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018

(Q30513802)
(P1545) 6
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(Q37374768)
(P1545) 11
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(Q40619109)
(P1545) 12
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P304) 259-266
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P407) (Q1860)

(P433) 2
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P478) 113
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P577) Saturday, January 1, 2005
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P1433) (Q332492)
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P1476) "Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence" (language: en)
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P2093) Caroline L Smith
(P1545) 1
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

Fareed Mirza
(P1545) 3
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

Michael J Palmowski
(P1545) 4
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

Pierre Coulie
(P1545) 7
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

Joerg Schneider
(P1545) 8
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

Eric Hoffman
(P1545) 9
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

Robert Hawkins
(P1545) 10
(P248)
(P698) 15386406
(P813) Sunday, April 8, 2018
(P854) http://europepmc.org/abstract/MED/15386406

(P2860) (Q40841260)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.20569
(P813) Sunday, January 21, 2018

(Q40790812)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.20569
(P813) Sunday, January 21, 2018

other details
description scientific article published in January 2005

External Links
(P356) 10.1002/IJC.20569
(P698) 15386406
(P5875) 8329410
(P8608) release_mfj732s46bgppiws53yweln6wu